People and Business News — 3/22
People News
Seqster PDM, Inc. announced the appointment of Bruno Villetelle, to its strategic advisory board.
Curebase has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
NNIT has appointed Camilla G. Møhl as its new SVP and Chief People, Communications and Marketing Officer.
ClinOne has named Andrea Valente as Chief Executive Officer.
Advanced Clinical announced that Dr. Andreas Amrein has joined the Executive Team as Senior Vice President of Asia-Pacific and Japan, as well as Managing Director for Europe and Canada.
MMS Holdings announced this week the addition of Dr. Robert Allen as Principal Medical Director to its Global Drug Safety and Pharmacovigilance team.
Total Diversity Clinical Trial Management announced Mark Hanley as a Board Member and Advisor.
Business News
Florence Healthcare announced that 285 million Americans now live within 25-miles of a Florence digital-workflow-equipped clinical research site.
Calyx announced its electronic data capture system has been selected by a leading pharmaceutical company to capture Real World Evidence data for a global, late-phase study.
Rho announced that it has been named the Autoimmune Diseases Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases.
Suvoda LLC launched a refreshed brand, to better reflect its leadership position as a global clinical trial technology company that specializes in highly complex studies, such as oncology, central nervous system, and rare disease.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
